Adverum Biotechnologies Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	26.06	60.65	75	68.43	34.2	62.42
Short-Term Investments	-	65.04	21.53	117.16	270.99	367.31
Cash & Short-Term Investments	26.06	125.69	96.53	185.59	305.19	429.73
Cash Growth	-82.99%	30.21%	-47.99%	-39.19%	-28.98%	158.82%
Other Receivables	-	-	-	-	5.71	-
Total Trade Receivables	-	-	-	-	5.71	-
Other Current Assets	2.85	5.61	6.25	5.01	6.25	4.71
Total Current Assets	28.91	131.3	102.77	190.6	317.15	434.44
Net Property, Plant & Equipment	39.49	45.22	49.79	113.86	119.06	47.1
Other Long-Term Assets	4	3.32	3.21	3.92	3.52	1.03
Total Assets	72.4	179.84	155.77	308.37	439.73	482.57
Accounts Payable	12.46	1.61	1.92	2.24	1.39	2.81
Accrued Expenses	26.48	15.62	12.58	16.77	18.05	13.59
Current Portion of Leases	5.81	5.67	5.48	13.24	1.89	4.47
Total Current Liabilities	44.75	22.9	19.98	32.25	21.32	20.87
Long-Term Leases	83.13	86.04	68.57	93.56	101.11	26.24
Other Long-Term Liabilities	0.18	0.19	-	1.05	1.11	1.11
Total Long-Term Liabilities	83.31	86.23	68.57	94.61	102.22	27.35
Total Liabilities	128.05	109.13	88.55	126.85	123.54	48.22
Common Stock	0	0	0	0.01	0.01	0.01
Additional Paid-in Capital	1,156	1,138	1,004	985.65	964.97	937.13
Accumulated Other Comprehensive Income	-0.44	-0.81	-0.47	-1.53	-0.71	-0.26
Retained Earnings	-1,211	-1,067	-936.02	-802.61	-648.08	-502.54
Shareholders' Equity	-55.65	70.71	67.22	181.52	316.19	434.35
Total Liabilities & Equity	72.4	179.84	155.77	308.37	439.73	482.57
Total Debt	88.94	91.71	74.04	106.8	102.99	30.71
Net Cash (Debt)	-62.88	33.99	22.49	78.79	202.19	399.02
Net Cash Growth	-	51.15%	-71.46%	-61.03%	-49.33%	198.25%
Net Cash Per Share	-2.91	1.72	2.23	7.94	20.62	46.86
Book Value	-55.65	70.71	67.22	181.52	316.19	434.35
Book Value Per Share	-2.58	3.57	6.67	18.29	32.25	51.01
Tangible Book Value	-55.65	70.71	67.22	181.52	316.19	434.35
Tangible Book Value Per Share	-2.58	3.57	6.67	18.29	32.25	51.01

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q